FDA May Reconsider SPF 30+ Sunscreen Labeling Requirement
This article was originally published in The Tan Sheet
Executive Summary
FDA may be willing to reconsider the sunscreen final monograph requirement that sunscreen products with SPFs over 30 may only state they are "30 plus," Office of Drug Evaluation V Director Robert DeLap, MD/PhD, said at an OTC "feedback" meeting on the reg in Rockville, Md. July 22. "We haven't closed any doors in a permanent sense" regarding the provision, DeLap told attendees.
You may also be interested in...
Sunscreen Anti-Aging Claim Ban Challenged At Industry "Feedback" Meeting
Sunscreen labeling language should go beyond sunburn prevention use and state the product's protective effects against premature aging and skin damage, sunscreen manufacturers and medical representatives told FDA at a OTC "feedback" meeting in Rockville, Md. July 22.
Sunscreen Anti-Aging Claim Ban Challenged At Industry "Feedback" Meeting
Sunscreen labeling language should go beyond sunburn prevention use and state the product's protective effects against premature aging and skin damage, sunscreen manufacturers and medical representatives told FDA at a OTC "feedback" meeting in Rockville, Md. July 22.
Sunscreen Anti-Aging Claim Ban Challenged At Industry "Feedback" Meeting
Sunscreen labeling language should go beyond sunburn prevention use and state the product's protective effects against premature aging and skin damage, sunscreen manufacturers and medical representatives told FDA at a OTC "feedback" meeting in Rockville, Md. July 22.